Breakthrough personalized mRNA vaccine cuts melanoma recurrence risk by 50% when combined with Keytruda, Moderna CEO reveals ...

A new study shows that TIL therapy, a personalized immunotherapy using a patient's own immune cells, significantly improves ...

Dear Dr. Roach: I was recently diagnosed with superficial spreading melanoma. I had a wide excision and was told to follow up ...

Glen Polyak thought he was out of options when his Stage 4 melanoma spread to his brain, until he became only the second ...

My 36-year-old sister recently noticed an unusual mole on her shoulder. She is scheduled for some tests. Her primary care ...

Patients with advanced melanoma experienced high response rates when treated with commercial Amtagvi in a real-world clinical ...

A new study published in JAMA Dermatology suggests U.S. veterans exposed to Agent Orange may face a higher risk of developing ...

University of Missouri researchers say combined AI models could improve early melanoma detection using 3D skin imaging.

A large database analysis finds that survival differences between men and women with metastatic melanoma disappear when ...

Cancer is one of the causes responsible for the most deaths worldwide. In 2020, for example, it resulted in ten million ...

Daniel Kirby, Chief Commercial Officer of Iovance, stated, “The real world Amtagvi data with impressive response rates, paired with unprecedented five-year durability and survival data, demonstrate a ...

Moderna and Merck's melanoma vaccine, combined with Keytruda, could halve cancer recurrence risk, marking a breakthrough in ...